Company Filing History:
4 out of 133 
2 out of 985 
2 out of 33 Years Active: 2013-2025
Introduction
Toshiro Shirakawa, an accomplished inventor based in Hyogo, Japan, has made significant strides in the field of cancer therapy. With a portfolio of 5 patents, his work focuses primarily on innovative approaches to immunotherapy, specifically utilizing tumor vaccines and immunosuppressive agents to enhance treatment efficacy.
Latest Patents
Shirakawa's latest patents include groundbreaking methods for cancer treatment through combination therapies. One notable patent describes a cancer therapy that utilizes a combination of an oral tumor vaccine and an immunosuppression inhibitor. This innovative approach aims to provide a robust anti-tumor agent incorporating DNA that encodes a WT1 protein alongside DNA for a GNB/LNB substrate-binding membrane protein. The transformed agent is designed to present the WT1 protein as an antigen, facilitating oral administration in patients. Another important patent details the development of an oral cancer vaccine, which leverages transformed agents expressive of the WT1 protein, ensuring applicability for patients with various HLA types, unlike conventional peptide vaccines.
Career Highlights
Throughout his career, Toshiro Shirakawa has worked with prestigious institutions and companies that reflect his commitment to advancing medical science. Notably, he has been affiliated with the National University Corporation Kobe University, contributing to research that blends academic rigor with innovative medical solutions. Additionally, his experience at Morishita Jintan Co., Ltd. has further enriched his expertise in developing practical applications of his research.
Collaborations
Collaborative efforts have been a cornerstone of Shirakawa’s accomplishments. He has worked alongside notable colleagues such as Takane Katayama and Masanori Asada, sharing insights and expertise that have led to the advancement of cancer treatment methodologies. Their collective efforts emphasize the importance of teamwork in the scientific community.
Conclusion
Toshiro Shirakawa stands out as an influential figure in the realm of cancer therapy innovations. With his remarkable patents and collaborations, he continues to push the boundaries of traditional cancer treatment, paving the way for new, effective, and accessible therapies for patients. His dedication to research and innovation represents a significant asset to the healthcare industry, promising a brighter future for cancer treatment options.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.